People: ZIOPHARM Oncology Inc (ZIOP.O)

ZIOP.O on Consolidated Issue listed on NASDAQ Capital Market

3.28USD
26 Aug 2014
Price Change (% chg)

$0.06 (+1.86%)
Prev Close
$3.22
Open
$3.27
Day's High
$3.32
Day's Low
$3.23
Volume
507,173
Avg. Vol
691,198
52-wk High
$5.58
52-wk Low
$2.87

Search Stocks

McInerney, Timothy 

Brief Biography

Mr. Timothy McInerney is an Independent Director of ZIOPHARM Oncology, Inc. Previously served as a director of ZIOPHARM, Inc. since July 2005. In June of 2007, Mr. McInerney joined Riverbank Capital, which specializes in financing for the biotech and specialty pharmaceutical industry, as a Partner. From 1992 to March 2007, Mr. McInerney was a Managing Director of Paramount BioCapital, Inc. where he oversaw the overall distribution of Paramount’s private equity product. Prior to 1992, Mr. McInerney was a research analyst focusing on the biotechnology industry at Ladenburg, Thalman & Co. Prior to that, Mr. McInerney held equity sales positions at Bear Sterns & Co. and Shearson Lehman Brothers, Inc. Mr. McInerney also worked in sales and marketing for Bristol-Myers Squibb. He received his B.S. in pharmacy from St. John’s University at New York. He also completed a post-graduate residency at the New York University Medical Center in drug information systems. Mr. McInerney currently serves as Chairman of the board of directors of Insite Vision Inc., an opthalmologic product development company, Emisphere Technologies, Inc., a biopharmaceutical company, and Edgemont Pharmaceuticals, LLC, a pharmaceutical company, and previously served on the board of directors of Manhattan Pharmaceuticals, Inc. a biopharmaceutical company.

Basic Compensation

Total Annual Compensation, Long-Term Incentive Plans, All Other, Fiscal Year Total,
-- -- -- --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Jonathan Lewis

1,692,670

Kevin Lafond

347,763

Caesar Belbel

912,418

Murray Brennan

--

Randal Kirk

--

James Cannon

--
As Of 30 Dec 2013
Search Stocks